Skip to results
Modify your search
NARROW
1-20 of 104
Authors: Michael A Pfaller
Journal Article
Evaluation of the Activity of Triazoles Against Non-fumigatus Aspergillus and Cryptic Aspergillus Species Causing Invasive Infections Tested in the SENTRY Program Open Access
Open Forum Infectious Diseases, Volume 11, Issue 11, November 2024, ofae532, https://doi.org/10.1093/ofid/ofae532
Published: 01 November 2024
Journal Article
1292. Activity of Omadacycline and Comparators Against 876 Bacterial Clinical Isolates from Patients with Bone and Joint Infections in the United States and Europe (2015–2022) Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1131, https://doi.org/10.1093/ofid/ofad500.1131
Published: 27 November 2023
Journal Article
868. In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations Open Access
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.061, https://doi.org/10.1093/ofid/ofac492.061
Published: 15 December 2022
Journal Article
347. Azole Activity against Filamentous Fungi Causing Invasive Infections in Patients from ICU and Non-ICU Units (2017-2021) Open Access
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.425, https://doi.org/10.1093/ofid/ofac492.425
Published: 15 December 2022
Journal Article
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections Open Access
Medical Mycology, Volume 60, Issue 5, May 2022, myac028, https://doi.org/10.1093/mmy/myac028
Published: 02 May 2022
Journal Article
In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms Open Access
JAC-Antimicrobial Resistance, Volume 3, Issue 4, December 2021, dlab177, https://doi.org/10.1093/jacamr/dlab177
Published: 14 December 2021
Journal Article
1076. Activity of Rezafungin and Comparator Antifungal Agents Tested Against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019-2020) Open Access
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Page S628, https://doi.org/10.1093/ofid/ofab466.1270
Published: 04 December 2021
Journal Article
1240. Ceftobiprole Activity against Drug-Resistant Staphylococcus aureus Clinical Isolates Collected in the United States from 2016 through 2020 Open Access
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S709–S710, https://doi.org/10.1093/ofid/ofab466.1432
Published: 04 December 2021
Journal Article
1258. Activity of a Series of Investigational Compounds Tested Against Invasive Fungal Isolates Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Pages S645–S646, https://doi.org/10.1093/ofid/ofaa439.1442
Published: 31 December 2020
Journal Article
1595. Ceftobiprole Activity against Gram-Positive Pathogens Causing Bone and Joint Infections in the United States from 2016 through 2019 Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S794, https://doi.org/10.1093/ofid/ofaa439.1775
Published: 31 December 2020
Journal Article
1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019) Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S644, https://doi.org/10.1093/ofid/ofaa439.1437
Published: 31 December 2020
Journal Article
1260. Activity of Manogepix (APX001A) against 2,669 Fungal Isolates from the SENTRY Surveillance Program (2018-2019) Stratified by Infection Type Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Pages S646–S647, https://doi.org/10.1093/ofid/ofaa439.1444
Published: 31 December 2020
Journal Article
1591. Updated Fluoroquinolone MIC Breakpoints: Impact on Susceptibility Rates in the United States Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Pages S580–S581, https://doi.org/10.1093/ofid/ofz360.1455
Published: 23 October 2019
Journal Article
2115. Activity of a Long-Acting Echinocandin Rezafungin and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates: SENTRY 2018 Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Page S716, https://doi.org/10.1093/ofid/ofz360.1795
Published: 23 October 2019
Journal Article
1590. Updated Aminoglycoside (AG) MIC Breakpoints (BP) to Minimize Adverse Events and Improve Outcome: Impact on Susceptibility (S) Rates Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Page S580, https://doi.org/10.1093/ofid/ofz360.1454
Published: 23 October 2019
Journal Article
665. In vitro Activity of Omadacycline Against Recent (2018) Bacterial Pathogens from the United States and Europe Obtained from Skin and Skin Structure, Respiratory, and Urinary Tract Infections Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Page S305, https://doi.org/10.1093/ofid/ofz360.733
Published: 23 October 2019
Journal Article
Comparison of the In Vitro Susceptibility of Ceftolozane-Tazobactam With the Cumulative Susceptibility Rates of Standard Antibiotic Combinations When Tested Against Pseudomonas aeruginosa From ICU Patients With Bloodstream Infections or Pneumonia Open Access
Open Forum Infectious Diseases, Volume 6, Issue 6, June 2019, ofz240, https://doi.org/10.1093/ofid/ofz240
Published: 20 May 2019
Journal Article
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_1, March 2019, Pages S79–S94, https://doi.org/10.1093/ofid/ofy358
Published: 15 March 2019
Journal Article
Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_1, March 2019, Pages S47–S53, https://doi.org/10.1093/ofid/ofy270
Published: 15 March 2019
Journal Article
Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997–2016 Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_1, March 2019, Pages S54–S62, https://doi.org/10.1093/ofid/ofy344
Published: 15 March 2019
